Volume 205, Issue 7: 3 October, 2016. Dr Greg Moore is the head of Inflammatory Bowel Disease at Monash Health in Melbourne. In between endoscopies he talked with MJA news and online editor Cate Swannell about biosimilars and a possible safety concern with multi-switching. Available as a video here.